MDxHealth Q4 Revenues Down 43 Percent, Continues Preparation for Prostate Cancer Test Launch | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – MDx Health today reported that revenues in the third quarter declined 43 percent year over year.

For the period ended September 30, total revenues were €378,000 ($511,000), down from €669,000 a year ago, with commercial revenues of €267,000 down 41 percent from €451,000 a year ago.

Net loss for the quarter increased 27 percent to €1.9 million from a net loss of €1.5 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.